Open Randomized Low Interventional Clinical Trial to Compare Efficiency in Control Symptoms Between Fluticasone Propionate/Formoterol K-haler (Medium Strength) vs High Strength ICS/LABA in the Treatment of Patients With Persistent Asthma
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Formoterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms EffICIENCY
- Sponsors Mundipharma Pharmaceuticals S.L.
Most Recent Events
- 18 Jul 2020 Status changed from withdrawn prior to enrolment to discontinued.
- 02 Jul 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 02 Jul 2020 Planned initiation date changed from 1 Apr 2020 to 11 Jun 2020.